rs7151505
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001395159.1(UNC79):c.1122+2018G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.549 in 151,868 control chromosomes in the GnomAD database, including 23,145 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.55 ( 23145 hom., cov: 31)
Consequence
UNC79
NM_001395159.1 intron
NM_001395159.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.205
Publications
6 publications found
Genes affected
UNC79 (HGNC:19966): (unc-79 homolog, NALCN channel complex subunit) The NALCN channel is responsible for Na(+) leak currents. The protein encoded by this gene, along with UNC80, is an accessory subunit of the NALCN channel that contributes to the Ca(2+) sensitivity of the channel. [provided by RefSeq, Sep 2016]
UNC79 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.623 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| UNC79 | NM_001395159.1 | c.1122+2018G>A | intron_variant | Intron 11 of 51 | ENST00000695012.1 | NP_001382088.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| UNC79 | ENST00000695012.1 | c.1122+2018G>A | intron_variant | Intron 11 of 51 | NM_001395159.1 | ENSP00000511643.1 |
Frequencies
GnomAD3 genomes AF: 0.549 AC: 83305AN: 151750Hom.: 23140 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
83305
AN:
151750
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.549 AC: 83354AN: 151868Hom.: 23145 Cov.: 31 AF XY: 0.550 AC XY: 40800AN XY: 74230 show subpopulations
GnomAD4 genome
AF:
AC:
83354
AN:
151868
Hom.:
Cov.:
31
AF XY:
AC XY:
40800
AN XY:
74230
show subpopulations
African (AFR)
AF:
AC:
21923
AN:
41382
American (AMR)
AF:
AC:
9675
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
1757
AN:
3468
East Asian (EAS)
AF:
AC:
1436
AN:
5146
South Asian (SAS)
AF:
AC:
2175
AN:
4824
European-Finnish (FIN)
AF:
AC:
5799
AN:
10546
Middle Eastern (MID)
AF:
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
AC:
38724
AN:
67924
Other (OTH)
AF:
AC:
1209
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1899
3799
5698
7598
9497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
718
1436
2154
2872
3590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1316
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.